Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1837-1839

  Ambler, Geoffrey R ^a   Chaitow, Jeffrey ^a   Rogers, Maureen ^a   McDonald, David W ^a   Ouvrier, Robert A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Bisphosphonates; Calcinosis; Juvenile dermatomyositis

Indexed keywords

ALENDRONIC ACID; DILTIAZEM; METHOTREXATE; PREDNISONE; PROBENECID;

ARTICLE; BONE MINERAL; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DRUG RESPONSE; FOLLOW UP; HUMAN; JUVENILE DERMATOMYOSITIS; LETHARGY; MALE; MUSCLE WEAKNESS; MYALGIA; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SYMPTOM; TREATMENT FAILURE;

ALENDRONATE; CALCINOSIS; CHILD; DERMATOMYOSITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; PREDNISONE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 24944490821     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002;28:833-57.
2. Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 2001;138:763-6.
3. Rider LG. Calcinosis in juvenile dermatomyositis: pathogenesis and current therapies. Ped Rheumatol OnLine Journal [Internet]2003;1:119-33. [accessed June 8, 2005]. Available from http://www.pedrheumonlinejournal.org/ April/calcinosis
4. Oliveri MB, Palermo R, Mautalen C, Hubscher O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 1996;23:2152-5.
5. Metzger AL, Singer FR, Bluestone R, Pearson CM. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma. N Engl J Med 1974;291:1294-6.